Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
Items 101–200 of 1,000
Conventional protein kinase C in the brain: 40 years later
Callender, J. A., & Newton, A. C. (2017) · Neuronal Signaling · doi:10.1042/ns20160005 · Cited by 113
Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor
Newton, A. C., & Brognard, J. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.02.002 · Cited by 100
“While we now understand that phorbol esters bind the C1 domain, a module present in various other signaling proteins [3], their most famous receptor is PKC.”
BackgroundC1 Domains: Structure and Ligand-Binding Properties
Das, J., & Rahman, G. M. S. (2014) · Chemical Reviews · doi:10.1021/cr300481j · Cited by 105
Wender, P. A., Baryza, J. L., Brenner, S. E., DeChristopher, B. A., Loy, B. A., Schrier, A. J., & Verma, V. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015270108 · Cited by 101
“Although PKC isoforms are in some cases functionally redundant, unique roles can be ascribed to each (64); thus, isotype selectivity is likely to be important in optimizing agents for desired functions while designing against unwanted activities or toxicities.”
Chen, J.-Q., Heldman, M. R., Herrmann, M. A., Kedei, N., Woo, W., Blumberg, P. M., & Goldsmith, P. K. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.07.022 · Cited by 100
“PKC is a validated therapeutic target for cancer [9,10].”
EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer
Wang, Y.-W., Cheng, H.-L., Ding, Y.-R., Chou, L.-H., & Chow, N.-H. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.04.004 · Cited by 110
Garg, R., Blando, J. M., Pérez, C. J., Abba, M. C., Benavides, F. J., & Kazanietz, M. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.042 · Cited by 104
Self-citationDiacylglycerol kinases as sources of phosphatidic acid
Cai, J., Abramovici, H., Gee, S., & Topham, M. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.010 · Cited by 109
“In other cases, DAG recruits but does not activate proteins such as protein kinase D, the Munc13 proteins, and the chimaerins [3].”
BackgroundOverarching roles of diacylglycerol signaling in cancer development and antitumor immunity
Cooke, M., & Kazanietz, M. G. (2022) · Science Signaling · doi:10.1126/scisignal.abo0264 · Cited by 103
Self-citationRutherford, C., Childs, S., Ohotski, J., McGlynn, L., Riddick, M., MacFarlane, S., Tasker, D., Pyne, S., Pyne, N. J., Edwards, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.455 · Cited by 100
“As these are involved in pro-survival responses (reviewed in refs Zhang et al. 34 and Griner and Kazanietz 35 ), we examined the effects of inhibiting these pathways individually and in combination.”
Ding, T., Li, Z., Hailemariam, T. K., Mukherjee, S., Maxfield, F. R., Wu, M.-P., & Jiang, X. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700401-jlr200 · Cited by 106
“DAG can regulate both conventional and novel PKCs (13), a family of serine/ threonine kinases that regulate a diverse set of cellular processes, including pro-apoptotic and pro-survival processes.”
BackgroundInfluentialNeuroprotective versus tumorigenic protein kinase C activators
Nelson, T. J., & Alkon, D. L. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.11.006 · Cited by 97
Biology of advanced uveal melanoma and next steps for clinical therapeutics
Luke, J. J., Triozzi, P. L., McKenna, K. C., Meir, E. G. V., Gershenwald, J. E., Bastian, B. C., Gutkind, J. S., Bowcock, A. M., STREICHER, H. Z., Patel, P. M., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12304 · Cited by 104
“Data demonstrating promising preclinical activity of combined vertical pathway inhibition at the levels of MEK and PKC (Chen et al., 2013) have led to the recent initiation of phase Ib/II trial of MEK162 and AEB071.”
BackgroundInfluentialDutta, D., Ray, S. S., Home, P., Larson, M. A., Wolfe, M. W., & Paul, S. (2011) · Stem Cells · doi:10.1002/stem.605 · Cited by 104
Protein kinase C-α and the regulation of diverse cell responses
Singh, R. K., Kumar, S., Gautam, P. K., Tomar, M. S., Verma, P. K., Singh, S. P., Kumar, S., & Acharya, A. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2017-0005 · Cited by 95
“Conventional or classical PKC isoform (cPKCs: α, βI, βII and γ) comprises a C1 domain (C1A and C1B) with two cysteine-rich zinc fingers that function as the binding site for diacylglycerol (DAG) and phorbol 12-myristate 13-acetate (PMA) and a C2 domain which functions as Ca2+-dependent membrane-binding modules (1, 2).”
Lee, J. O., Kim, N., Lee, H. J., Lee, Y. W., Kim, S. J., Park, S. H., & Kim, H. S. (2016) · Scientific Reports · doi:10.1038/srep18923 · Cited by 96
Nishida‐Aoki, N., Izumi, Y., Takeda, H., Takahashi, M., Ochiya, T., & Bamba, T. (2020) · Metabolites · doi:10.3390/metabo10020067 · Cited by 97
“PKCδ is a novel subtype of PKC isoforms activated without Ca2+ [26] by being recruited to cellular membrane together with PKD in response to DG [39], and activates downstream signals in pulmonary microvascular endothelial cells [40].”
BackgroundLi, S., Wu, T., Lu, Y., Wang, J., Yu, F.-H., Yang, M., Huang, Y., Li, Z.-J., Wang, S.-L., Huang, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101596 · Cited by 94
Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M
Lee, H.-J., Schaefer, G., Heffron, T. P., Shao, L., Ye, X., Sideris, S., Malek, S., Chan, E., Merchant, M., La, H., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0357 · Cited by 90
Wender, P. A., Buschmann, N., Cardin, N. B., Jones, L. R., Kan, C., Kee, J., Kowalski, J. A., & Longcore, K. E. (2011) · Nature Chemistry · doi:10.1038/nchem.1074 · Cited by 90
“Significantly, we found that yuanhuapin is a highly potent (subnanomolar) ligand for PKC ( Table 1 ), a target that has implications for treating diseases including cance”
Free Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes
Sieber, J., & Jehle, A. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00186 · Cited by 94
Protein kinase C in cancer: The top five unanswered questions
Cooke, M., Magimaidas, A., Casado‐Medrano, V., & Kazanietz, M. G. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22617 · Cited by 95
“massive effort taking into consideration the distinctive patterns of expression and complex regulatory mechanisms governing PKC activation in individual cell types.(6,8) Based on the complexities described above, in this review we will focus on the most puzzling questions to be addressed in the field of PKC and cancer.”
BackgroundSelf-citationSourbier, C., Scroggins, B. T., Ratnayake, R., Prince, T. L., Lee, S., Lee, M.-J., Nagy, P., Lee, Y. H., Trepel, J. B., Beutler, J. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.007 · Cited by 97
“Because of the lack of selectivity of available PKC modulators, the role played by each isozyme in tumorigenesis is not well understood (Griner and Kazanietz, 2007).”
Best, M. D., Rowland, M. M., & Bostic, H. E. (2011) · Accounts of Chemical Research · doi:10.1021/ar200060y · Cited by 89
Pahujaa, M., Anikin, M., & Goldberg, G. S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.010 · Cited by 88
A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle
Cohen, E. E. W., Zhu, H., Lingen, M. W., Martin, L. E., Kuo, W., Choi, E. A., Kocherginsky, M., Parker, J. S., Chung, C. H., & Rosner, M. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0377 · Cited by 99
“or possesses tumor suppressor function (3).”
BackgroundThe Dual Roles of the Atypical Protein Kinase Cs in Cancer
Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.07.010 · Cited by 92
“Introduction The extended protein kinase C (PKC) family comprises three subfamilies: the atypical (aPKCs; PKCζ and PKCλ/ι), the conventional (cPKCs; PKCα, PKCβ, and PKCγ), and the novel (nPKCs; PKCδ, PKCε, PKCη, and PKCθ) (Griner and Kazanietz, 2007; Newton and Brognard, 2017).”
BackgroundProtein Kinase C (PKC) Isozymes and Cancer
Kang, J. (2014) · New Journal of Science · doi:10.1155/2014/231418 · Cited by 106
“This is particularly true during short- or long-term 12-Otetradecanolyphorbol 13-acetate (TPA) treatment, whereby short-term TPA treatment increases PKC activation, but long-term treatment downregulates PKC isozyme function [2, 27].”
BackgroundTargeting Protein Kinase C for Cancer Therapy
He, S., Li, Q., Huang, Q., & Cheng, J. Q. (2022) · Cancers · doi:10.3390/cancers14051104 · Cited by 91
Crucial Role of Phospholipase Cε in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester
Ikuta, S., Edamatsu, H., Li, M., Hu, L., & Kataoka, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3245 · Cited by 85
“To make a connection between the TPA-initiated signal and Rap1 activation, we focused on the DAG/TPA effector RasGRPs (15).”
BackgroundResultInfluentialDynamics and Membrane Interactions of Protein Kinase C
Igumenova, T. I. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00565 · Cited by 86
Passos, G. F., Medeiros, R., Marcon, R., Nascimento, A. F. Z., Calixto, J. Β., & Pianowski, L. F. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.019 · Cited by 89
PDK1: A signaling hub for cell migration and tumor invasion
Gagliardi, P. A., di Blasio, L., & Primo, L. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.07.003 · Cited by 93
Wealth of Opportunity - The C1 Domain as a Target for Drug Development
Blumberg, P. M., Kedei, N., Lewin, N. E., Yang, D., Czifra, G., Pu, Y., Peach, M. L., & Márquez, V. E. (2008) · Current Drug Targets · doi:10.2174/138945008785132376 · Cited by 90
Batarseh, A. M., Li, J., & Papadopoulos, V. (2010) · Biochemistry · doi:10.1021/bi100020e · Cited by 94
“PKCε is abundant in endocrine, neuronal, and immune cells (19;20).”
BackgroundHoller, C., Hofbauer, J. P., Denk, U., Heyder, C., Hofbauer, S. W., Greil, R., & Egle, A. (2009) · Blood · doi:10.1182/blood-2008-06-160713 · Cited by 82
DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling
Scholz, R., Regner, J., Theil, A., Erlmann, P., Holeiter, G., Jähne, R., Schmid, S., Haußer, A., & Olayioye, M. A. (2008) · Journal of Cell Science · doi:10.1242/jcs.036251 · Cited by 82
“The main cellular kinases that directly bind and are activated by phorbol esters are the classical PKCs (α, β, γ), the novel PKCs (δ, η, ε, θ), and the PKD family members PKD1/PKCμ, PKD2 and PKD3/PKCν (Griner and Kazanietz, 2007).”
BackgroundDevelopmentally regulated sphingolipid synthesis in African trypanosomes
Sutterwala, S. S., Hsu, F., Sevova, E. S., Schwartz, K. J., Zhang, K., Key, P. N., TURK, J. W., Beverley, S. M., & Bangs, J. D. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06393.x · Cited by 82
“In mammalian cells ceramide is generally pro-apototic (Lahiri and Futerman, 2007), and DAG can be either pro-apototic or pro-survival depending on its interactions with protein kinase C isoforms (Griner and Kazanietz, 2007).”
BackgroundMYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Tao, L., Mohammad, M. A., Milazzo, G., Moreno‐Smith, M., Patel, T. D., Zorman, B., Badachhape, A., Hernandez, B. E., Wolf, A. B., Zeng, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31331-2 · Cited by 83
Kho, D. H., Bae, J. A., Lee, J. H., Cho, H. J., Cho, S. H., Lee, J. H., Seo, Y.-W., Ahn, K. Y., Chung, I., & Kim, K. K. (2008) · Gut · doi:10.1136/gut.2008.150938 · Cited by 82
Mandal, J., Shiue, C.-N., Chen, Y.-C., Lee, M., Yang, H., Chang, H., Hu, C., Liao, P.-C., Hui, L.-C., You, R.-I., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.003 · Cited by 86
G Protein–Coupled Receptor Connectivity to NF-κB in Inflammation and Cancer
Fraser, C. C. (2008) · International Reviews of Immunology · doi:10.1080/08830180802262765 · Cited by 85
“Evidence suggests PKCs play a role in cancer development and progression [35, 36, 40] and a role in inflammation [41, 42].”
Panayiotou, R., Miralles, F., Pawlowski, R., Diring, J., Flynn, H. R., Skehel, M., & Treisman, R. (2016) · eLife · doi:10.7554/elife.15460 · Cited by 79
“In NIH3T3 cells, the phorbol ester TPA, which activates ERK through cooperation between Protein Kinase C (PKC) family members and RasGRP (see Griner and Kazanietz, 2007 for review), induced transcription of MRTF-SRF target genes in an ERK-dependent manner (Figure 3A, Gineitis and Treisman, 2001).”
BackgroundRosario, F. J., Nathanielsz, P. W., Powell, T. L., & Jansson, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03888-2 · Cited by 85
Exocyst function regulated by effector phosphorylation
Chen, X.-W., Leto, D., Xiao, J., Goss, J., Wang, Q., Shavit, J. A., Xiong, T., Yu, G., Ginsburg, D., Toomre, D., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2226 · Cited by 76
“Conventional PKCs have long been recognized as key regulators of exocytosis, particularly in neuronal system”
Morgan, B. J., Dey, S., Johnson, S. W., & Kozlowski, M. C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902324j · Cited by 76
Micallef, J., Taccone, M. S., Mukherjee, J., Croul, S. E., Caldwell-Busby, J., Moran, M. F., & Guha, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4783 · Cited by 76
“EGF stimulation of EGFR can activate PKC (23), with PKC activation leading to MARCKS phosphorylation (14).”
BackgroundSu, S., Yeh, C., Lin, C., Hsieh, Y., Chuang, C., Tang, C., Lee, Y., & Yang, S. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12760 · Cited by 80
Ogbourne, S. M., & Parsons, P. G. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.07.002 · Cited by 80
Jiang, X., Goldberg, I. J., & Park, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_2 · Cited by 75
Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway
Ziemba, B. P., Burke, J. E., Masson, G., Williams, R. L., & Falke, J. J. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.03.001 · Cited by 74
Majhi, A., Rahman, G. M. S., Panchal, S., & Das, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.075 · Cited by 74
Yu, W., Jin, C., Lou, X., Han, X., Li, L., He, Y., Zhang, H., Ma, K., Zhu, J., Cheng, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029450 · Cited by 74
“PPKCE is a member of the protein kinase C (PKC) family, whose members phosphorylate a wide variety of protein targets and are involved in diverse cellular signaling pathways [40].”
BackgroundContribution of individual PKC isoforms to breast cancer progression
Urtreger, A. J., Kazanietz, M. G., & Joffé, E. B. D. K. (2011) · IUBMB Life · doi:10.1002/iub.574 · Cited by 74
“In addition, it has been proposed that in prostate cancer cells PKCd can also trigger an autocrine apoptotic loop through the secretion of TNFa and TRAIL (6).”
BackgroundSelf-citationRac regulates the interaction of fascin with protein kinase C in cell migration
Parsons, M., & Adams, J. C. (2008) · Journal of Cell Science · doi:10.1242/jcs.022509 · Cited by 79
“Jo ur na l o f C el l S ci en ce 2810 Conventional PKCs are activated by a complex process that involves priming phosphorylation events in the cytoplasm, and release of autoinhibition and membrane translocation in response to increased concentrations of intracellular Ca2+ and diacylglycerol (Griner and Kazanietz, 2007…”
BackgroundInfluentialMembrane fluidity matters: Hyperthermia from the aspects of lipids and membranes
Csoboz, B., Balogh, G. E., Kúsz, E., Gombos, I., Péter, M., Crul, T., Güngör, B., Haracska, L., Bogdanovics, G., Török, Z., et al. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.808765 · Cited by 75
“Moreover, the heat-induced accumulation of PS and the BA-induced enhancement of DAG may play a positive regulatory role in PKC activation and consequently in HS induction, since both PS and DAG are essential cofactors of PKC [64,65], but can be differently affected by the different stressors.”
BackgroundInfluentialBalogh, G. E., Péter, M., Liebisch, G., Horváth, I., Török, Z., Nagy, E., Maslyanko, A., Benkö, S., Schmitz, G., Harwood, J. L., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.011 · Cited by 78
S-Phase-specific Activation of PKCα Induces Senescence in Non-small Cell Lung Cancer Cells
Oliva, J. L., Caino, M. C., Senderowicz, A. M., & Kazanietz, M. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707576200 · Cited by 66
Self-citationIannotti, F. A., Pagano, E., Guardiola, O., Adinolfi, S., Saccone, V., Consalvi, S., Piscitelli, F., Gazzerro, E., Busetto, G., Carrella, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06267-1 · Cited by 73
Wang, Z., Humphries, B. A., Xiao, H., Jiang, Y., & Yang, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554246 · Cited by 71
“Many PKC isozymes have been shown to play crucial roles in cancer initiation, cell migration and cancer metastasis (40), it is thus important to identify new regulators that can down-regulate PKC expression thus inactivating PKC-mediated oncogenic signaling.”
BackgroundMelzer, C., von der Ohe, J., & Hass, R. (2018) · Stem Cells · doi:10.1002/stem.2829 · Cited by 70
COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
Garg, R., Blando, J. M., Pérez, C. J., Lal, P., Feldman, M. D., Smyth, E. M., Ricciotti, E., Großer, T., Benavides, F. J., & Kazanietz, M. G. (2018) · Oncogene · doi:10.1038/s41388-018-0318-9 · Cited by 73
Self-citationHeparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis
Boyango, I., Barash, U., Naroditsky, I., Li, J., Hammond, E., Ilan, N., & Vlodavsky, I. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2962 · Cited by 69
“known for its ability to activate PKC, a group of at least 10 related isoforms that are highly implicated in cancer progression (45, 46).”
Histone Hyperacetylation Up-regulates Protein Kinase Cδ in Dopaminergic Neurons to Induce Cell Death
Jin, H., Kanthasamy, A., Harischandra, D. S., Kondru, N., Ghosh, A., Panicker, N., Anantharam, V., Rana, A., & Kanthasamy, A. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576702 · Cited by 68
Zeidan, Y. H., Wu, B. X., Jenkins, R. W., Obeid, L. M., & Hannun, Y. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8967com · Cited by 80
“mammalian cells to UV-induced apoptosis (21, 22).”
Phosphorylation of RalB Is Important for Bladder Cancer Cell Growth and Metastasis
Wang, H., Owens, C., Chandra, N., Conaway, M. R., Brautigan, D. L., & Theodorescu, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0952 · Cited by 67
“RalB has been implicated in bladder cancer migration and metastasis (10) and PKC is known to play an important role in cellular differentiation and in malignancy and metastasis (33-35).”
BackgroundKim, J., Thorne, S. H., Sun, L., Huang, B., & Mochly‐Rosen, D. (2010) · Oncogene · doi:10.1038/onc.2010.415 · Cited by 68
“…MMP-9 activities. αV5-3 treatment also reduced lung seeding of tumor cells and decreased cell migration, effects that were accompanied by a reduction in NFκB-activity and cell surface levels of the CXCL12 receptor, CXCR4. αV5-3 treatment caused no apparent toxicity in non-tumor bearing naïve mice.”
Gundimeda, U., McNeill, T. H., Elhiani, A. A., Schiffman, J. E., Hinton, D. R., & Gopalakrishna, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356899 · Cited by 70
Chen, L.-G., Hung, L., Tsai, K., Pan, Y., Tsai, Y., Li, Y., & Liu, Y. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700329 · Cited by 67
Doller, A., Winkler, C., Azrilian, I., Schulz, S., Hartmann, S., Pfeilschifter, J. M., & Eberhardt, W. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr024 · Cited by 71
Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity
Vinken, M., Doktorova, T. Y., Decrock, E., Leybaert, L., Vanhaecke, T., & Rogiers, V. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230903061215 · Cited by 68
“TPA mimics the action of diacylglycerol, an activator of PKC, which regulates different signal transduction pathways and other cellular metabolic activities (Goel et al., 2007; Griner and Kazanietz, 2007).”
BackgroundActivation of Nuclear Factor κB (NF-κB) in Prostate Cancer Is Mediated by Protein Kinase C ϵ (PKCϵ)
Garg, R., Blando, J. M., Pérez, C. J., Wang, H., Benavides, F. J., & Kazanietz, M. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398925 · Cited by 66
Self-citationSutcliffe, E. L., Bunting, K. L., He, Y., Li, J., Phetsouphanh, C., Seddiki, N., Zafar, A., Hindmarsh, E. J., Parish, C. R., Kelleher, A. D., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.030 · Cited by 74
“Dysregulation of the PKC family has also been implicated in pathologies such as cancer and tumor metastasis (Griner and Kazanietz, 2007; Martiny-Baron and Fabbro, 2007).”
Backgrounddo Carmo, A., Balça-Silva, J., Matias, D., & Lopes, M. C. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23615 · Cited by 68
“com Cancer Biology & Therapy 291 is a selective inhibitor of PKCβ that in in vitro studies induced a significant reduction of glioma cell proliferation.(47,73) However, when enzastaurin was tested in a randomized phase III trial, in patients with recurrent GBM, the results were disappointing, indicating that other pat…”
BackgroundResultAsano, S., Kitatani, K., Taniguchi, M., Hashimoto, M., Zama, K., Mitsutake, S., Igarashi, Y., Takeya, H., Kigawa, J., Hayashi, A., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00121-12 · Cited by 66
“Ceramide is a bioactive lipid that plays a role in cell death, proliferation, and differentiation (17, 42), whereas diacylglycerol activates protein kinase C and promotes cell survival and proliferation (16).”
BackgroundPuerarin: A review of its mechanisms of action and clinical studies in ophthalmology
Meng, F., Guo, B., Ma, Y.-Q., Li, K., & Niu, F. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154465 · Cited by 69
Baumann, Ü., Fernández‐Sáiz, V., Rudelius, M., Lemeer, S., Rad, R., Knorn, A.-M., Slawska, J., Engel, K. C., Jeremias, I., Li, Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3740 · Cited by 71
The Multifunctional Protein Kinase C-ε in Cancer Development and Progression
Jain, K., & Basu, A. (2014) · Cancers · doi:10.3390/cancers6020860 · Cited by 67
“sometime opposing roles in cellular processes [15].”
Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3)
You, R.-I., Chang, Y.-C., Chen, P., Wang, W.-S., Hsu, T.-L., Yang, C.-Y., Lee, C.-T., & Hsieh, S.-L. E. (2007) · Blood · doi:10.1182/blood-2007-09-114850 · Cited by 65
Magno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64
“Both products of the reaction have roles in intracellular signaling, with IP3 production leading to Ca 2+ release from intracellular stores, and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
BackgroundKugelmann, D., Rotkopf, L. T., Radeva, M. Y., García‐Ponce, A., Walter, E., & Waschke, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-31408-3 · Cited by 65
Abhilash, P. C., Srivastava, P., Jamil, S., & Singh, N. (2010) · Environmental Science and Pollution Research · doi:10.1007/s11356-010-0400-5 · Cited by 63
“They can act as co-carcinogens or tumor promoters ( Griner and Kazanietz 2007 ).”
BackgroundRegulation of Mucin Gene Expression by CREB via a Nonclassical Retinoic Acid Signaling Pathway
Kim, S. W., Hong, J. S., Ryu, S.-H., Chung, W.-C., Yoon, J., & Koo, J. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02385-06 · Cited by 71
“PKCs are a family of serine/threonine kinases that assume important physiological functions and are highly activated in certain malignancies (19).”
BackgroundInfluentialChauvin, L., Goupille, C., Blanc, C., Pinault, M., Domingo, I., Guimaraes, C., Bougnoux, P., Chevalier, S., & Mahéo, K. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.012 · Cited by 63
PKC Delta (PKCδ) Promotes Tumoral Progression of Human Ductal Pancreatic Cancer
Mauro, L. V., Grossoni, V. C., Urtreger, A. J., Yang, C., Colombo, L. L., Morandi, A., Pallotta, M. G., Kazanietz, M. G., Joffé, E. B. D. K., & Puricelli, L. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181bce796 · Cited by 62
“Furthermore, each PKC isozyme displays a unique tissue distribution, subcellular localization, and substrate specificity.(4) The mechanisms involved in PKC activation have been extensively studied.”
BackgroundSelf-citationExploiting the balance between life and death: Targeted cancer therapy and “oncogenic shock”
Sharma, S. V., & Settleman, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.001 · Cited by 65
Benjamin, D. I., Li, D. S., Lowe, W., Heuer, T., Kemble, G., & Nomura, D. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00240 · Cited by 60
Intramolecular Conformational Changes Optimize Protein Kinase C Signaling
Antal, C. E., Violin, J. D., Kunkel, M. T., Skovsø, S., & Newton, A. C. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.02.008 · Cited by 63
“PKC isozymes are critical in processing signals that drive cellular functions such as proliferation, apoptosis, and differentiation (Griner and Kazanietz, 2007;Newton, 2010).”
BackgroundLindoso, R. S., Collino, F., & Vieyra, A. R. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.08.08 · Cited by 64
Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way
Kopeina, G. S., Prokhorova, E. A., Lavrik, I. N., & Zhivotovsky, B. (2018) · Cell Proliferation · doi:10.1111/cpr.12467 · Cited by 61
Lipid Players of Cellular Senescence
Millner, A., & Atilla-Gokcumen, G. E. (2020) · Metabolites · doi:10.3390/metabo10090339 · Cited by 55
“has been implicated in various diseases including cancer [14] and cardiac disease [15].”
BackgroundProtein Kinase C-δ Mediates Kidney Tubular Injury in Cold Storage–Associated Kidney Transplantation
Zhu, J., Zhang, G., Song, Z., Xiang, X., Shu, S., Liu, Z., Yang, D., Wei, Q., & Dong, Z. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019101060 · Cited by 62
Differential signaling during macropinocytosis in response to M-CSF and PMA in macrophages
Yoshida, S., Gaeta, I., Pacitto, R., Krienke, L., Alge, O., Gregorka, B., & Swanson, J. A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00008 · Cited by 56
“We speculate that PLCγ-generated DAG activates both PKC and Ras (Figure 5) (Hancock, 2003; Griner and Kazanietz, 2007).”
BackgroundMethodInfluentialAnraku, K., Fukuda, R., Takamune, N., Misumi, S., Okamoto, Y., Otsuka, M., & Fujita, M. (2010) · Biochemistry · doi:10.1021/bi9019274 · Cited by 60
Kajimoto, T., Sawamura, S., Tohyama, Y., Mori, Y., & Newton, A. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.184028 · Cited by 60
Zhou, Y., Yin, H., Li, X., Li, Z., Ai, S., & Lin, H. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.07.004 · Cited by 61
Wagner, R., Stübiger, G., Veigel, D., Wuczkowski, M., Lanzerstorfer, P., Weghuber, J., Karteris, E., Nowikovsky, K., Wilfinger-Lutz, N., Singer, C., et al. (2017) · OncoTarget · doi:10.18632/oncotarget.14591 · Cited by 55
Cyclooxygenase inhibitors: Scope of their use and development in cancer chemotherapy
Khan, M. N. A., & Lee, Y. S. (2009) · Medicinal Research Reviews · doi:10.1002/med.20182 · Cited by 59
“Phorbol 12-myristate 13-acetate (PMA) functions as an environmental tumor promoter and modulates diverse cellular responses including proliferation and apoptosis.(137) Chi et al.”
BackgroundAnnexins — Scaffolds modulating PKC localization and signaling
Hoque, M., Rentero, C., Cairns, R. F., Tebar, F., Enrich, C., & Grewal, T. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.012 · Cited by 65
af Gennäs, G. B., Talman, V., Aitio, O., Ekokoski, E., Finel, M., Tuominen, R. K., & Yli‐Kauhaluoma, J. T. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900229p · Cited by 59
“This synthesis commenced with monohydrolysis of the THP-protected diester (3) (Scheme 7) and the subsequent N-acylation of 3-(trifluoromethyl)benzylamine with 37 to give 38.”
BackgroundMethodInfluential
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.